Skip to main content
. 2023 Aug 6;9(8):e18994. doi: 10.1016/j.heliyon.2023.e18994

Table 1.

Characteristics of Delta and Omicron variant cases included in the study.






Variables Delta Omicron p-value OR (CI 95%)
N 157 159
Age, median (IQR), years 35 (24–46) 38 (26–51) 0.136
Male sex, n (%) 81 (51.5) 67 (42.1) 0.114 0.380 (−0.087–0.849)
Symptoms
Cough, n (%) 96 (61.1) 86 (54.0) 0.213 0.289 (−0.182–0.762)
Headache, n (%) 89 (56.6) 66 (41.5) 0.010 0.610 (0.142–1.083)
Runny nose, n (%) 79 (50.3) 58 (36.4) 0.017 0.566 (0.093–1.042)
Fever, n (%) 75 (47.7) 61 (38.3) 0.112 0.384 (−0.087–0.857)
Sore throat, n (%) 54 (34.3) 62 (38.9) 0.416 −0.198 (−0.683–0.286)
Myalgia, n (%) 34 (21.6) 10 (6.2) <0.001 1.411 (0.635–2.272)
Loss of taste, n (%) 39 (24.8) 14 (8.8) <0.001 1.227 (0.539–1.966)
Loss of smell, n (%) 29 (18.4) 12 (7.5) 0.004 1.018 (0.266–1.827)
Dyspnea, n (%) 12 (7.6) 15 (9.4) 0.688 −0.229 (−1.117–0.637)
Weakness, n (%) 12 (7.6) 9 (5.6) 0.507 0.321 (−0.663–1.341)
Stuffy nose, n (%) 6 (3.8) 2 (1.2) 0.172 1.134 (−0.607–3.464)
O2 saturation <95%, n (%) 5 (3.1) 4 (2.5) 0.749 0.242 (−1.315–1.879)
Diarrhea, n (%) 4 (2.5) 8 (5.0) 0.378 −0.704 (−2.238–0.638)
Respiratory distress, n (%) 4 (2.5) 6 (3.7) 0.750 −0.404 (−1.997–1.057)
Vomiting, n (%) 2 (1.2) 0.246
Arthralgia, n (%) 1 (0.6) 1 (0.6) 1.000 0.013 (−4.356–4.381)
Asymptomatic, n (%) 12 (7.6) 30 (18.8) 0.004 −1.030 (−1.836–−0.283)
Hospitalization, n (%) 5 (3.8) 5 (3.2) 1.000 0.154 (−1.340–1.647)
Death, n (%) 1 (0.6) 1.000

Significant associations are in bold.